CRISPR/deadCas9-based high-throughput gene doping analysis (HiGDA): A proof of concept for exogenous human erythropoietin gene doping detection.
Talanta
; 258: 124455, 2023 Jun 01.
Article
in En
| MEDLINE
| ID: mdl-36933297
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Erythropoietin
/
CRISPR-Cas Systems
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Talanta
Year:
2023
Document type:
Article
Affiliation country:
South Korea